All Subjects Medicine Surgery Pathology Anatomy Pharmacology Social & Preventive Medicine Microbiology Gynaecology & Obstetrics Dental Physiology Biochemistry Pediatrics
Showing 18289 questions
Sort:
9872 Medicine

A 56-year-old man is diagnosed with the metabolic syndrome, which consists of hypertension, insulin resistance, dyslipidemia, and abdominal obesity. He has no prior history of cardiac or vascular disease and is otherwise well. His fasting T-chol is 270 mg/dL, HDL 50 mg/dL, LDL 150 mg/dL, and triglycerides 150 mg/dL. His Framingham risk calculation approximates a 10- year risk for cardiac events of 10%-20%.For the above patient with dyslipidemia, select the most appropriate treatment.

Afibric acid derivatives (clofibrate, gemfibrozil)
Bnicotinic acid
Cbile acid-binding resins (cholestyramine, colestipol)
Dhepatic hydroxymethylglutaryl coenzyme A (HMG-Co) reductase inhibitors (lovastatin, simvastatin, pravastatin)
Medicine
View Explanation →